Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia
Authors:
- Andrés Ceballos-GarzónAndrés Ceballos-Garzón
- Gloria CortesGCGloria Cortes
- Florent MorioFMFlorent Morio
- Edna L. Zamora-CruzEZEdna L. Zamora-Cruz
- Melva Y. LinaresMLMelva Y. Linares
- Beatriz E. ArizaBABeatriz E. Ariza
- Sandra L. ValderramaSVSandra L. Valderrama
- Javier R. GarzónJGJavier R. Garzón
- Carlos A. Alvarez-MorenoCACarlos A. Alvarez-Moreno
- Patrice Le PapePatrice Le Pape
- Claudia M. Parra-GiraldoClaudia M. Parra-Giraldo
Open Access
- 23 May 2019
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 19 (1) , 1-10
Abstract
The introduction of MALDI-TOF MS in the clinical microbiology laboratory has modified the approaches for the identification of fungi. Thanks to this tool, it is possible to identify cryptic species, which possess critical susceptibility patterns. Clinical strains were identified using the MicroScan and MALDI-TOF MS systems. Discrepant results from both methods were investigated using ITS rDNA barcoding. Finally, these isolates were also tested for in vitro susceptibility. The percentage of agreement between both methods to 498 yeast isolates was of 93.6% (32 discrepant isolates). The concordance of ITS sequencing with MALDI-TOF MS was higher (99%) than that of MicroScan (94%). Several of these discordant yeasts displayed high MICs for antifungal agents. Our study highlights the need of the MS and molecular approaches such as MALDI-TOF MS and ITS rDNA barcoding for the correct identification of emerging or cryptic yeast species; besides, some of these could be multidrug resistant. This work was the first experience in the implementation of the MALDI-TOF MS technology in Colombia. We found the first uncommon yeasts including Candida auris and we could identify Trichosporon faecalis. Our work highlights a clear necessity of an accurate yeast identification as a much more pertinent technique than the susceptibility profiles, because the most unusual yeasts exhibit resistance profiles to the few available antifungals.Keywords
Funding Information
- Hospital Universitario de San Ignacio (2014-52)
- Pontificia Universidad Javeriana (7710)
This publication has 27 references indexed in Scilit:
- CandidaInfections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal AgentsBioMed Research International, 2013
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Identification of Yeasts Is Contingent on Robust Reference SpectraPLOS ONE, 2011
- Emerging fungal infections in immunocompromised patientsF1000 Medicine Reports, 2011
- Genome Variation in Cryptococcus gattii, an Emerging Pathogen of Immunocompetent HostsmBio, 2011
- MALDI-TOF mass spectrometry proteomic phenotyping of clinically relevant fungiMolecular BioSystems, 2010
- Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific RegionInternational Journal of Antimicrobial Agents, 2009
- Consensus multi-locus sequence typing scheme forCryptococcus neoformansandCryptococcus gattiiMedical Mycology, 2009
- Identification of Medically Important Candida and Non- Candida Yeast Species by an Oligonucleotide ArrayJournal of Clinical Microbiology, 2007
- Rapid Identification of Pathogenic Fungi Directly from Cultures by Using Multiplex PCRJournal of Clinical Microbiology, 2002
- Sequence Analysis of the Ribosomal DNA Intergenic Spacer 1 Regions of Trichosporon SpeciesJournal of Clinical Microbiology, 2002